Table 4 Comparison between active and inactive lupus nephritis (LN) regarding clinical presentations and laboratory findings
Parameter | Inactive LN (n = 45) | Active LN (n = 16) | Test of Significance |
|---|---|---|---|
Sex | |||
Male | 34 (75.6) | 12 (75) | FET P = 1 |
Female | 11 (24.4) | 4 (25) | |
Fever | |||
Absent | 29 (64.4) | 7 (43.8) | x2 = 2.1 P = 0.15 |
Present | 16 (35.6) | 9 (56.3) | |
Mucocutaneous | |||
Absent | 23 (51) | 5 (31.2) | X2 = 1.87 P = 0.17 |
Present | 22 (49) | 11 (68.8) | |
Arthritis | |||
Absent | 32 (71) | 11 (68.8) | FET P = 1 |
Present | 13 (29) | 5 (31.2) | |
Serositis | |||
Absent | 32 (71) | 10 (62.5) | FET P = 0.54 |
Present | 13 (29) | 6 (37.5) | |
Vasculitis | |||
Absent | 45 (100) | 14 (87.5) | FET P = 0.06 |
Present | 0.0 | 2 (12.5) | |
Medications | |||
2 medications | 16 (35.6) | 2 (12.5) | FET P = 0.11 |
> 2 medications | 29 (64.4) | 14 (87.5) | |
Anemia | |||
Absent | 33 (73.3) | 15 (93.8) | FET P = 0.15 |
Present | 12 (26.7) | 1 (6.3) | |
Leucopenia | |||
Absent | 42 (93.3) | 16 (100) | FET 0.56 |
Present | 3 (6.7) | 0.0 | |
Thrombocytopenia | |||
Absent | 44 (97.8) | 15 (93.8) | FET P = 0.45 |
Present | 1 (2.2) | 1 (6.3) | |
Liver function test | |||
Normal | 42 (93.3) | 14 (87.5) | FET P = 0.6 |
Elevated | 3 (6.7) | 2 (12.5) | |
APL antibodies | |||
Negative | 36 (80) | 14 (87.5) | FET P = 0.7 |
Positive | 9 (20) | 2 (12.5) | |